Quarterly report pursuant to Section 13 or 15(d)

Equity-Based Compensation (Schedule Of Stock Option Activity) (Details)

v2.4.0.8
Equity-Based Compensation (Schedule Of Stock Option Activity) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 9 Months Ended 12 Months Ended
Sep. 27, 2014
Dec. 28, 2013
Equity-Based Compensation [Abstract]    
Shares, Outstanding 1,827  
Shares, Granted 711  
Shares, Exercised (434)  
Shares, Forfeited (48)  
Shares, Outstanding 2,056 1,827
Shares, Exercisable 526  
Weighted-average grant price, Outstanding $ 37.37  
Weighted-average grant price, Granted $ 58.04  
Weighted-average grant price, Exercised $ 32.33  
Weighted-average grant price, Forfeited $ 37.25  
Weighted-average grant price, Outstanding $ 45.58 $ 37.37
Weighted-average grant price, Exercisable $ 38.37  
Weighted-average remaining contractual term, Outstanding 2 years 8 months 12 days 2 years 7 months 6 days
Weighted-average remaining contractual term, Exercisable 1 year 4 months 24 days  
Aggregate intrinsic value, Outstanding $ 74,160 [1]  
Aggregate intrinsic value, Outstanding 54,978 [1] 74,160 [1]
Aggregate intrinsic value, Exercisable $ 17,743 [1]  
Closing price of common stock $ 77.72 $ 71.98
[1] Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company's common stock on the last trading day of the period) and the exercise price of awards that were in-the- money.  The closing price of the Company's common stock at December 28, 2013, and September 27, 2014, was $77.72 and $77.76, respectively.